← Evidence map

ReviewOncotarget2022

The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer.

Alexander W Pohlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35198099